INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 109 filers reported holding INTERSECT ENT INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,651,000 | +10.5% | 558,777 | +7.7% | 0.01% | +20.0% |
| Q4 2021 | $14,165,000 | +2.6% | 518,678 | +2.2% | 0.01% | 0.0% |
| Q3 2021 | $13,802,000 | +1960.0% | 507,438 | +1194.5% | 0.01% | – |
| Q2 2021 | $670,000 | -18.1% | 39,200 | 0.0% | 0.00% | – |
| Q1 2021 | $818,000 | -8.9% | 39,200 | 0.0% | 0.00% | – |
| Q4 2020 | $898,000 | +33.0% | 39,200 | -5.3% | 0.00% | – |
| Q3 2020 | $675,000 | +17.4% | 41,400 | -2.6% | 0.00% | – |
| Q2 2020 | $575,000 | +55.0% | 42,500 | +35.8% | 0.00% | – |
| Q1 2020 | $371,000 | -49.7% | 31,300 | +5.7% | 0.00% | – |
| Q4 2019 | $737,000 | +46.5% | 29,600 | 0.0% | 0.00% | – |
| Q3 2019 | $503,000 | -25.4% | 29,600 | 0.0% | 0.00% | – |
| Q2 2019 | $674,000 | -98.1% | 29,600 | -97.4% | 0.00% | -100.0% |
| Q1 2019 | $36,326,000 | +18.1% | 1,129,902 | +3.5% | 0.02% | +4.3% |
| Q4 2018 | $30,771,000 | -2.9% | 1,091,936 | -1.0% | 0.02% | +9.5% |
| Q3 2018 | $31,695,000 | -41.6% | 1,102,449 | -23.9% | 0.02% | -44.7% |
| Q2 2018 | $54,270,000 | -7.6% | 1,449,121 | -3.0% | 0.04% | -9.5% |
| Q1 2018 | $58,727,000 | +23.6% | 1,494,323 | +1.9% | 0.04% | +23.5% |
| Q4 2017 | $47,522,000 | +16.9% | 1,466,730 | +12.4% | 0.03% | +13.3% |
| Q3 2017 | $40,651,000 | +56.1% | 1,305,007 | +40.1% | 0.03% | +50.0% |
| Q2 2017 | $26,036,000 | +4541.0% | 931,505 | +2746.9% | 0.02% | – |
| Q1 2017 | $561,000 | +41.7% | 32,720 | 0.0% | 0.00% | – |
| Q4 2016 | $396,000 | -33.6% | 32,720 | -13.0% | 0.00% | -100.0% |
| Q3 2016 | $596,000 | +22.6% | 37,620 | 0.0% | 0.00% | – |
| Q2 2016 | $486,000 | -92.0% | 37,620 | -88.3% | 0.00% | -100.0% |
| Q1 2016 | $6,097,000 | -15.6% | 320,880 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $7,220,000 | +23.7% | 320,880 | +28.7% | 0.01% | +20.0% |
| Q3 2015 | $5,835,000 | +55.5% | 249,370 | +90.2% | 0.01% | +66.7% |
| Q2 2015 | $3,753,000 | +109.2% | 131,080 | +88.8% | 0.00% | +200.0% |
| Q1 2015 | $1,794,000 | – | 69,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |